We are live on ! Find out more
CVS icon

CVS Health

Positive
Neutral
Negative
Sentiment 3-Months
Positive 62.8%
Neutral 29.9%
Negative 7.3%

Positive
Zacks Investment Research
17 hours ago
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
Positive
Zacks Investment Research
17 hours ago
CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?
CVS Health (CVS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CVS Health Corporation (CVS) Soars to 52-Week High, Time to Cash Out?
Positive
Zacks Investment Research
17 hours ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
PRNewsWire
19 hours ago
Aetna provider survey reveals increased payer trust and tangible benefits of digital tools to improve patient outcomes
Providers give a 6.1 payer trust score, up from 5.4 in the previous study Providers weigh in on the potential of technology-enabled solutions to reduce administrative burden and save valuable time HARTFORD, CT, July 15, 2026 /PRNewswire/ -- Aetna®, a CVS Health® company (NYSE: CVS) today announced findings from the second Aetna Provider Survey. The Aetna Provider Survey is a quarterly study that polls the U.S. provider market to better understand their perceptions on payers and the industry, today and into the future.
Aetna provider survey reveals increased payer trust and tangible benefits of digital tools to improve patient outcomes
Positive
Benzinga
19 hours ago
FTC Says CVS Caremark Settlement Could Save Consumers Upto $13 Billion
The Federal Trade Commission (FTC) on Tuesday settled with CVS Health Corp. (NYSE:CVS) subsidiary Caremark, requiring the pharmacy benefit manager to overhaul key business practices aimed at lowering prescription drug costs, expanding transparency, and improving access to pharmacy services.
FTC Says CVS Caremark Settlement Could Save Consumers Upto $13 Billion
Neutral
Reuters
19 hours ago
Simpler prior authorizations, digital tools boost trust in insurers, Aetna president says
Less burdensome prior authorization procedures in which clinicians must have procedures and medicines preapproved by health plans and digital solutions for managing ​care have boosted trust in insurers, Aetna President Steve Nelson said on ‌Wednesday.
Simpler prior authorizations, digital tools boost trust in insurers, Aetna president says
Neutral
PRNewsWire
1 day ago
CVS Caremark Announces Agreement with FTC To Further Advance Industry-Leading Approaches to Transparency and Affordability
WOONSOCKET, R.I., July 14, 2026 /PRNewswire/ -- CVS Caremark today announced a global settlement with the Federal Trade Commission (FTC) which further advances the company's leadership in delivering greater affordability for prescription drugs.
CVS Caremark Announces Agreement with FTC To Further Advance Industry-Leading Approaches to Transparency and Affordability
Neutral
Reuters
1 day ago
CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance
CVS Health's Caremark has finalized a settlement with the U.S. Federal Trade Commission in which ​it agreed to curb use of after-market discounts known as ‌rebates and count consumers' TrumpRx purchases toward their deductibles, an FTC spokesperson said on Tuesday.
CVS settles with FTC, agrees to count TrumpRx drug purchases towards insurance
Positive
Zacks Investment Research
1 day ago
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why CVS Health (CVS) is a Top Value Stock for the Long-Term
Neutral
PRNewsWire
5 days ago
CVS Health declares quarterly dividend
WOONSOCKET, R.I., July 10, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
CVS Health declares quarterly dividend